MOLECULAR INFORMATION
Molecular information
- Type
- Short peptide bioregulator · claimed prostatic tissue modulator
Prostamax is one of the Khavinson family of “short bioregulator peptides”.
Claims vs evidence
- Prostatic tissue support — preclinical only, single-group
- BPH-spectrum benefit — claimed; no Western RCT
Why we grade it D
Same single-source evidence pattern as the rest of the family.
Frequently asked questions
- What is Prostamax?
- A short Khavinson-family bioregulator peptide marketed for prostatic-tissue support, including BPH-spectrum and post-prostatitis recovery claims.
- Is Prostamax authorised for urological use?
- No — not authorised by any major Western regulator. Standard BPH treatments (alpha-blockers, 5-alpha-reductase inhibitors) have decades of evidence; Prostamax does not.
- Why grade D?
- Same single-research-group evidence pattern as the rest of the Khavinson family.